Abstract
The development of treatment regimes for African-American HIV-infected crack cocaine users has often been based on assumptions about compliance with medication regimes rather than evidence. This study sought to obtain baseline information on the adherence to antiretroviral medications by members of this important risk population in Houston, Texas. It was found that for only 5 of a range of 16 antiviral medications was there a significant correlation between levels of compliance reported by respondents and their beliefs as to how effective these medications are. Medication compliance was also found not to be associated with frequency of crack cocaine use in the month prior to interview. Furthermore, irrespective of both gender and their reported extent of medication compliance, the respondents tended to report positive relationships with their treating physician, with higher levels of satisfaction reported by women. These results suggest that the majority of African-American crack cocaine users are able to comply with HIV treatment regimes, with more than half (53%) claiming full compliance for one or more medications, and a further one third (31%) claiming compliance more than half the time. Moreover, these findings suggest that they will continue to take antiretroviral medications even if they have doubts about the effectiveness of these medications.
Similar content being viewed by others
References
Andersen, R., Bozzette, S., Shapiro, M., and St Clair, P. (2000). Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. Health Services Research, 35, 389-416.
Arnsten, J. H., Demas, P. A., Farzadegan, H., Grant, R. W., Gourevitch, M. N., Chang, C. J., Buono, D., Eckholdt, H., Howard, A. A., and Schoenbaum, E. E. (2001). Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring. Clinical Infectious Diseases, 33, 1417-1423.
Avants, S., Warburton, L., Hawkins, K., and Margolin, A. (2000). Continuation of high-risk behavior by HIV-positive drug users: Treatment implications. Journal of Substance Abuse Treatment, 19, 15-22.
Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Robertson, M., Zolopa, A. R., and Moss, A. (2001). Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181-1183.
Booth, R., Kwiatkowski, C., and Weissman, G. (1999). Health-related service utilization and HIV risk behaviors among HIV-infected injection drug users and crack smokers. Drug and Alcohol Dependence, 55, 69-78.
Broers, B., Morabia, A., and Hirschel, B. (1994). A cohort study of drug users' compliance with zidovudine treatment. Archives of Internal Medicine, 154, 1121-1127.
Camacho, L. M., Williams, M. L., Vogtsberger, K. N., and Simpson, D. D. (1995). Cognitive readiness of drug injectors to reduce AIDS risks. American Journal on Addictions, 4, 49-55.
Carpenter, C., Fischl, M., Hammer, S., Hirsch, M., Jacobsen, D., Katzenstein, D., Montaner, J., Richman, D., Saag, M., Schooley, R., Thompson, M., Vella, S., Yeni, P., and Volberding, P. (1998). Antiretroviral infection for HIV infection in 1998: Updated recommendations of the International AIDS Society-USA panel. Journal of the American Medical Association, 280, 78-86.
Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., and McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124-133.
Celentano, D., Vlavov, D., Cohn, S., Shadle, V., Obasanjo, O., and Moore, R. D. (1998). Self-reported antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 544-546.
Chitwood, D., McBride, D., French, M., and Comerford, M. (1999). Health care need and utilization: A preliminary comparison of injection drug users, other illicit drug users and nonusers. Substance Use and Misuse, 34, 727-746.
Cockerham, W. C. (1997). Lifestyles, social class, demographic characteristics and health behavior. In D. S. Gochman (Ed.) Handbook of health behavior research. New York: Plenum Press.
Crystal, S. (1992). Health-care barriers and utilization patterns among intravenous drug users with HIV disease. AIDS and Public Policy Journal, 7, 187-198.
Cunningham, W., Hays, R., Ettl, M., Dixon, W., Liu., R., Beck, K., and Shapiro, M. (1998). The prospective effect of access to medical care on health-related quality of life outcomes in patients with symptomatic HIV disease. Medical Care, 36, 295-306.
Eldred, L. J., Wu, A. W., Chaisson, R. R., and Moor, R. D. (1998). Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18, 117-125.
Fleishman, J., Hsia, D., and Hellinger, F. (1994). Correlates of medical service utilization among people with HIV infection. Health Services Research, 5, 527-548.
Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., and Levy, R. (2002). Patient Education and Counseling, 46, 93-108.
Freeman, R. C., Rodriquez, G. M., and French, J. F. (1996). Compliance with AZT treatment regimen of HIV-seropositive injection drug users: A neglected issue. AIDS Education and Prevention, 8, 58-71.
Frick, P. A., Gal, P., Lane, T. W., and Sewell, P. C. (1998). Antiretroviral medication compliance in patients with AIDS. AIDS Patient Care and STDs, 12, 463-470.
Gebo, K. A., Keruly, J., and Moore, R. D. (2003). Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. Journal of General Internal Medicine, 18, 104-111.
Gerbert, B., Maguire, B., Bleecker, T., Coates, T., and McPhee, S. (1991). Primary care physicians and AIDS: Attitudinal and structural barriers to care. Journal of the American Medical Association, 266, 2837-2842.
Janssen, R. S., Holtgrave, D. R. Valdiserri, R. O., Shepherd, M., Gayle, H. D., and De Cock, K. M. (2001). The serostatus approach to fighting the HIV epidemic: Prevention strategies for infected individuals. American Journal of Public Health, 91, 1019-1024.
Jeffe, D. B., Meredith, K. L., Mundy, L. M., and Fraser, V. J. (1998). Factors associated with HIV-infected patients' recognition and use of HIV medications. Journal of Acquired Immune Deficiency Syndromes, 19, 350-360.
Kwiatkowski, C., and Booth, R. (1998). HIV-seropositive drug users and unprotected sex. AIDS and Behavior, 2, 151-159.
Mor, V., Fleishman, J., Dresser, M., and Piette, J. (1992). Variation in health service use among HIV-infected patients. Medical Care, 30, 17-29.
Muma, R., Ross, M., Parcel, G., and Pollard, R. (1995). Zidovudine adherence among individuals with HIV infection. AIDS Care, 7, 439-447.
Nannis, E., Temoshok, L., Smith, M., and Jenkins, R. (1993). Perceptions of AZT: Implications for adherence to medical regimens. Journal of Applied Biobehavioral Research, 1, 39-54.
O'Connor, P., Molde, S., Henry, S., Shockcor, W., and Schottenfeld, R. (1992). Human immunodeficiency virus infection in intravenous drug users: A model for primary care. American Journal of Medicine, 93, 382-386.
O'Connor, P., Selwyn, P., and Schottenfeld, R. (1994). Medical care for injecting drug users with human immunodeficiency virus infection. New England Journal of Medicine, 33, 450-459.
Palella, K., Delaney, K., Moorman, A., Loveless, M., Fuhrer, J., Satten, G., Aschman, D. J., and Holmberg, S. D. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection: HIV outpatient study investigators. New England Journal of Medicine, 338, 853-860.
Perry, S., Ryan, J., Ashman, T., and Jacobsberg, L. (1992). Refusal of zidovudine by HIV-positive patients. AIDS, 6, 514-516.
Reiber, C., Ramirez, A., Parent, D., and Rawson, R. A. (2002). Predicting treatment success at multiple timepoints in diverse patient populations of cocaine-dependent individuals. Drug and Alcohol Dependence, 68, 35-48.
Sadiq, S. T., Taylor, S., Kaye, S., Bennett, J., Johnstone, R., Byrne, P., Copas, A. J., Drake, S. M., Pillay, D., and Weller, I. (2002). The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS, 16, 219-225.
Sambamoorthi, U., Warner, L., Crystal., S., and Walkup, J. (2000). Drug abuse, methadone treatment and health services use among injection drug users with AIDS. Drug and Alcohol Dependence, 60, 77-89.
Samet, J., Libman, H., Steger, K., Dhawan, R., Chen, J., Shevitz, A., Dewees-Dunk, R., Levenson, S., Kufe, D., and Craven, D. (1992). Compliance with zidovudine therapy in patients infected with human immunodeficiency virus type 1: A cross-sectional study in a municipal hospital clinic. American Journal of Medicine, 92, 495-502.
Selwyn, P., Budner, N., Wasserman, W., and Arno, P. (1993). Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports, 108, 492-500.
Siegal, K., and Gorey, E. (1997). HIV-infected women: Barriers to AZT use. Social Science and Medicine, 45, 15-22.
Simpson, D. D., Knight, K., and Ray, S. (1993). Psychosocial correlates of AIDS-risk drug use and sexual behaviors. AIDS Education and Prevention, 5, 121-130.
Simpson, D. D., Camacho, L. M., Vogtsberger, K. N., Williams, M. L., Stephens, R. C., Jones, A., and Watson, D. D. (1994). Reducing AIDS risks through community outreach for drug injectors. Psychology of Addictive Behaviors, 8, 86-101.
Singh, N., Squier, C., Sivek, C., Wagener, M., Hong Nguyen, M., and Yu, V. L. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care, 8, 261-269.
Smith, P. C., and Page, J. B. (1996). Medication therapy among intravenous drug users (IDUs) with HIV infection. AIDS Patient Care and STDs, 10, 101-110.
Smith, S., and Kirking, D. (1999). Access and use of medications in HIV disease. Health Services Research, 34, 123-144.
Solomon, L., Frank, R., Vlahov, D., and Astemborski, J. (1991). Utilization of health services in a cohort of intravenous drug users with known HIV-1 status. American Journal of Public Health, 81, 1285-1290.
Sorensen, J. L., Mascovich, A., Wall, T. L., DePhillipis, D., Batki, S. L., and Chesney, M. (1998). Medication adherence strategies for drug abusers with HIV/AIDS. AIDS Care, 10, 297-312.
Stein, M. D., Piette, J., Mor, V., Wachtel, T. J., Fleishman, J., Mayer, K. H., and Carpenter, C. J. (1991). Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. Journal of General Internal Medicine, 6, 35-40.
Strathdee, S. A., Palepu, A., Cornelisse, P. G. A., Yip, B., O'Shaughnessy, M. V., Montaner, J. S. G., Schecter, M. T., and Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280, 547-549.
Weatherby, N. L., Needle, R., Cesari, H., Booth, R., McCoy, C.B., Watters, J. K., Williams, M., and Chitwood, D. D. (1994). Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning, 17, 347-355.
Williams, M., Bowen, A., Ross, M., Freeman, R., and Elwood, W. (2000). Perceived compliance with AZT dosing among a sample of African American drug users. International Journal of STD and AIDS, 11, 57-63.
Williams, M., Timpson, S., Crisp, B., Bowen, A., Ross, M., and Keel, K. B. (2002). Final report: An investigation of condom use by HIV-positive African American crack cocaine smokers. Houston: School of Public Health, University of Texas Health Science Center at Houston.
Zhang, H., Dornadula, G., Beaumont, M., Livornese, L., Van Uitert, B., Henning, K., and Pomerantz, R. J. (1998). Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. New England Journal of Medicine, 399, 1803-1809.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crisp, B.R., Williams, M., Timpson, S. et al. Medication Compliance and Satisfaction with Treatment for HIV Disease in a Sample of African-American Crack Cocaine Smokers. AIDS Behav 8, 199–206 (2004). https://doi.org/10.1023/B:AIBE.0000030250.33931.af
Issue Date:
DOI: https://doi.org/10.1023/B:AIBE.0000030250.33931.af